EYE worth a watch today. in addition to the very strong revenue results which have yet to be factored into EYE share price US proposal for reimbursement changes to significantly benefit EYE came out last 24 hours.
sight sciences closest competitor (but with inferior device) up 20% overnight in US trading full details over on the EYE CMS reimbursement changes thread
- Forums
- ASX - Day Trading
- Day trading pre-market open July 12
EYE worth a watch today. in addition to the very strong revenue...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online